These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Hypothalamic releasing and inhibiting hormones]. Vanha-Perttula T Duodecim; 1973 Oct; 20(1):1282-98. PubMed ID: 4361282 [No Abstract] [Full Text] [Related]
26. The present concept of the nature of hypothalamic hormones stimulating and inhibiting the release of pituitary hormones. Schally AV; Kastin AJ Triangle; 1969; 9(1):19-25. PubMed ID: 4980829 [No Abstract] [Full Text] [Related]
27. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation. Walter R; Griffiths EC; Hooper KC Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290 [No Abstract] [Full Text] [Related]
28. Biosynthesis of hypothalamic hypophysiotropic factors. Reichlin S; Mitnick M Front Neuroendocrinol; 1973; 0(0):61-88. PubMed ID: 4137560 [No Abstract] [Full Text] [Related]
29. Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides. Grant GF; Vale W Curr Top Exp Endocrinol; 1974; 2():37-72. PubMed ID: 4208407 [No Abstract] [Full Text] [Related]
30. Structure-activity studies of MSH-release-inhibiting hormone. Celis ME; Hase S; Walter R FEBS Lett; 1972 Nov; 27(2):327-30. PubMed ID: 4352026 [No Abstract] [Full Text] [Related]
31. Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease. Kastin AJ; Barbeau A Can Med Assoc J; 1972 Dec; 107(11):1079-81. PubMed ID: 4640811 [TBL] [Abstract][Full Text] [Related]
32. Intramolecular motion in peptide determined by 13C NMR: a spin-lattice relaxation time-study on MSH-release-inhibiting factor. Deslauriers R; Walter R; Smith IC FEBS Lett; 1973 Nov; 37(1):27-32. PubMed ID: 4585031 [No Abstract] [Full Text] [Related]
33. [Progress in the study of hypothalamic hormones]. Ito T Horumon To Rinsho; 1975 Jan; 23(1):1-5. PubMed ID: 168014 [No Abstract] [Full Text] [Related]
35. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report. Wycis HT Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056 [No Abstract] [Full Text] [Related]
36. [Releasing hormone]. Yanaibara N Horumon To Rinsho; 1973 Nov; 21(11):1073-8. PubMed ID: 4205272 [No Abstract] [Full Text] [Related]